A passion for science and a commitment to dermatology

We are all in on skin

Dermavant Sciences, a subsidiary of Roivant Sciences, is a biopharmaceutical company committed to fostering unprecedented change and unparalleled impact in immuno-dermatology. Our mission is to make healthier skin a reality for the millions of people around the world living with chronic skin conditions. That’s why we’re hard at work developing novel treatments that deliver groundbreaking science exactly where patients need it — their skin.

Because skin is more than superficial — it’s where we live, every moment of every day.

Dermavant Voices
Patient Focused Innovation

“The ability to transform lives”

Todd Zavodnick
Chief Executive Officer

“A passion for helping people”

Philip M Brown, MD, JD
Chief Medical Officer

“Fundamentally changing the lives of patients”

David Rubenstein, MD, PhD
Chief Scientific Officer



We Will Transform Dermatology.


Latest News

May 24, 2022

FDA Approves Dermavant’s VTAMA® (tap ...

March 25, 2022

Dermavant Showcases New Long-Term Durability and T ...

March 11, 2022

Dermavant to Present New Data from the Phase 3 PSO ...